Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)

NCT02111707 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT02111707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02111707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Timing of Indomethacin Administration for the Prevention of Post-ERCP Pancreatitis (PEP)
Lead sponsor
University of Alberta
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
September 30, 2017
Enrollment
534 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis